P Bastit

666 total citations
29 papers, 541 citations indexed

About

P Bastit is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, P Bastit has authored 29 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 9 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in P Bastit's work include Breast Cancer Treatment Studies (9 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Lesions and Carcinomas (4 papers). P Bastit is often cited by papers focused on Breast Cancer Treatment Studies (9 papers), Cancer Treatment and Pharmacology (7 papers) and Breast Lesions and Carcinomas (4 papers). P Bastit collaborates with scholars based in France, Belgium and Netherlands. P Bastit's co-authors include Bernard Asselain, Bernard Chevallier, B Chevallier, Y Graïc, A Kunlin, Véronique Mosseri, J P Basuyau, Corinne Veyret, Christian Duval and P Brunelle and has published in prestigious journals such as Cancer, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

P Bastit

28 papers receiving 514 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Bastit France 12 288 209 133 94 87 29 541
Zofia Kołosza Poland 16 204 0.7× 166 0.8× 180 1.4× 109 1.2× 57 0.7× 60 613
Monika Dufmats Sweden 12 375 1.3× 198 0.9× 125 0.9× 231 2.5× 86 1.0× 13 619
Sven‐Börje Ewers Sweden 14 346 1.2× 292 1.4× 132 1.0× 255 2.7× 150 1.7× 27 765
Debbi H. Conlon United States 8 419 1.5× 91 0.4× 182 1.4× 189 2.0× 53 0.6× 12 715
Saverio Danese Italy 16 408 1.4× 199 1.0× 228 1.7× 114 1.2× 99 1.1× 31 880
Malti Kshirsagar United States 9 218 0.8× 176 0.8× 201 1.5× 151 1.6× 92 1.1× 9 603
Peter Lim Canada 16 316 1.1× 138 0.7× 172 1.3× 145 1.5× 108 1.2× 32 1.5k
Marcella Falchetti Italy 16 274 1.0× 107 0.5× 225 1.7× 126 1.3× 39 0.4× 19 803
Toshifumi Kameyama Japan 14 247 0.9× 129 0.6× 328 2.5× 165 1.8× 59 0.7× 27 688
Pamela Tan Australia 5 341 1.2× 273 1.3× 182 1.4× 86 0.9× 55 0.6× 6 643

Countries citing papers authored by P Bastit

Since Specialization
Citations

This map shows the geographic impact of P Bastit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Bastit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Bastit more than expected).

Fields of papers citing papers by P Bastit

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Bastit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Bastit. The network helps show where P Bastit may publish in the future.

Co-authorship network of co-authors of P Bastit

This figure shows the co-authorship network connecting the top 25 collaborators of P Bastit. A scholar is included among the top collaborators of P Bastit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Bastit. P Bastit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Plachot, M, J. Selva, Jean‐Philippe Wolf, P Bastit, & J. de Mouzon. (2002). Conséquences d’une dysmorphie ovocytaire sur la fécondation et le développement embryonnaire après injection intracytoplasmique d’un spermatozoïde. Étude prospective, multicentrique. Gynécologie Obstétrique & Fertilité. 30(10). 772–779. 19 indexed citations
2.
Bastit, Laurent, Emmanuel Blot, P. Debourdeau, et al.. (2001). Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers. International Journal of Radiation Oncology*Biology*Physics. 49(1). 139–146. 46 indexed citations
3.
Vinholes, J., RE Coleman, Denis Lacombe, et al.. (1999). Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion. British Journal of Cancer. 80(1-2). 221–228. 50 indexed citations
4.
Boccara, Claude, et al.. (1998). Apport du CA 15.3 en cancérologie mammaire. Immuno-analyse & Biologie Spécialisée. 13(1). 19–25. 3 indexed citations
5.
6.
Chevallier, B, P Bastit, Y Graïc, et al.. (1993). The Centre H. Becquerel studies in inflammatory non metastatic breast cancer. Combined modality approach in 178 patients. British Journal of Cancer. 67(3). 594–601. 46 indexed citations
7.
Cappelaere, P, J Chauvergne, P Bastit, et al.. (1992). Phase II trial of pirarubicin in epidermoid carcinoma of the head and neck. European Journal of Cancer. 28(2-3). 484–485. 3 indexed citations
8.
Bonneterre, Jacques, P. Fargeot, R Metz, et al.. (1991). Tetracosactrin vs. methylprednisolone in the prevention of emesis in patients receiving FEC regimen for breast cancer. European Journal of Cancer and Clinical Oncology. 27(7). 849–852. 2 indexed citations
9.
Delpech, Bertrand, Bernard Chevallier, Jean‐Pierre Julien, et al.. (1990). Serum hyaluronan (hyaluronic acid) in breast cancer patients. International Journal of Cancer. 46(3). 388–390. 72 indexed citations
10.
Chevallier, B, et al.. (1990). A prognostic score in histological node negative breast cancer. British Journal of Cancer. 61(3). 436–440. 30 indexed citations
11.
Hurteloup, P, P. Armand, Martina Schneider, et al.. (1989). Phase II trial of idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. European Journal of Cancer and Clinical Oncology. 25(3). 423–428. 12 indexed citations
12.
Bastit, P, et al.. (1989). Biochemical exploration of azoospermia: interest of the seminal transferrin assay. Human Reproduction. 4(3). 265–269. 4 indexed citations
13.
Chevallier, B, et al.. (1989). [What are the prognostic factors in operable breast cancer without histologic axillary lymph node invasiveness. Results of an uni- and multifactorial analysis].. PubMed. 76(1). 51–60. 2 indexed citations
14.
Chevallier, Bernard, Véronique Mosseri, P Bastit, et al.. (1988). Prognostic value of estrogen and progesterone receptors in operable breast cancer: Results of a univariate and multivariate analysis. Cancer. 62(12). 2517–2524. 80 indexed citations
15.
Chevallier, B, et al.. (1988). [Prognostic value of estrogen and progesterone receptors in the operable breast cancer: results of a uni- and multifactorial analysis].. PubMed. 75(1). 23–36. 2 indexed citations
16.
Chevallier, B, et al.. (1988). [Human calcitonin in neoplastic hypercalcemia. Results of a prospective randomized trial].. PubMed. 17(45). 2375–7. 3 indexed citations
17.
Chevallier, Bernard, Bernard Asselain, A Kunlin, et al.. (1987). Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis. Cancer. 60(4). 897–902. 63 indexed citations
18.
Chevallier, B, et al.. (1987). Prognostic value of estrogen and progesterone receptors in operable breast cancer. Journal of Steroid Biochemistry. 28. 21–21. 27 indexed citations
19.
Bastit, P, et al.. (1983). [Morphologic parameters of sperm. 1) Syndromes].. PubMed. 12(4). 363–71.
20.
Lepillé, D. & P Bastit. (1979). [Therapeutical evaluation on neoplasia-related pain (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 55(15-16). 791–5. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026